Πέμπτη 7 Μαΐου 2020

Emapalumab in Children with Primary Hemophagocytic Lymphohistiocytosis

Emapalumab in Children with Primary Hemophagocytic Lymphohistiocytosis: Hemophagocytic lymphohistiocytosis is a rare disorder characterized by pathologic immune activation and hyperinflammation with deleterious effects on multiple organs. Primary hemophagocytic lymphohistiocytosis is a heterogeneous disorder that is associated with impaired cytotoxic function of…


Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου

Αρχειοθήκη ιστολογίου